John Ledoux, MD
Interventional Cardiology · Mobile, ALNPI 1912043795
Payments from drug & device makers
Across 336 payments — averaging $6960.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1.3M
- Janssen Research & Development, LLC$695K
- Boehringer Ingelheim International GmbH$184K
- Amgen$76K
- Boehringer Ingelheim Pharma GmbH & Co.kg$70K
- Astrazeneca UK Limited$56K
- plus $4K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 54 | $1,254,954 |
| Janssen Research & Development, LLC | 37 | $694,895 |
| Boehringer Ingelheim International GmbH | 138 | $183,612 |
| Amgen | 7 | $75,751 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 11 | $69,510 |
| Astrazeneca UK Limited | 4 | $56,416 |
| Array Biopharma Inc | 2 | $1,250 |
| Abbott | 8 | $425 |
| Penumbra, Inc. | 10 | $361 |
| Medtronic | 22 | $345 |
| Atricure, Inc. | 5 | $181 |
| Esperion Therapeutics, Inc. | 2 | $146 |
| Boston Scientific | 1 | $140 |
| Cardiovascular Systems Inc. | 7 | $140 |
| Boehringer Ingelheim | 5 | $89 |
| Johnson & Johnson | 6 | $86 |
| Merck | 5 | $82 |
| Abiomed | 2 | $69 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $60 |
| Baxter Healthcare | 1 | $44 |
| Philips North America LLC | 1 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| Argon Medical Devices, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
| Lantheus Medical Imaging, Inc. | 1 | $13 |
| Chiesi USA, Inc. | 1 | $12 |
How this compares
$2,338,709 in reported general payments places this provider in the 95th percentile of 109 interventional cardiology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Mobile
- Chad AlfordMobile$461K
- Kevin DeandradeMobile$239K
- John TrotterMobile$122K
- Mir HashimiMobile$110K
- John GallaMobile$93K
- Ahmed SubahiMobile$37K
- Stanley ThorntonMobile$23K
- Mohammed ElzeneiniMobile$23K
- Benjamin CitrinMobile$11K
- James GladdenMobile$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.